CT45 Protein Predicts Longer Survival Times in Advanced-stage Ovarian Cancer, Study Reports

CT45 Protein Predicts Longer Survival Times in Advanced-stage Ovarian Cancer, Study Reports
A protein called CT45 predicts which ovarian cancer patients will respond to platinum-based chemotherapy and is associated with extended survival in these patients, being a new prognostic marker for ovarian cancer, a study shows. The findings also suggest that strategies boosting CT45 levels could improve chemotherapy’s efficacy. The research, “Multi-level Proteomics Identifies CT45 as a

Knowledge is power when living with ovarian cancer.

Get access to the web’s leading Ovarian Cancer news & insights for as little as 16¢/day.
Subscribe or to access all post and page content.

One comment

Leave a Comment

Your email address will not be published. Required fields are marked *